SOX2 and glioblastoma: Additionally, the downregulation of SNHG6 in glioblastoma cells induces the expression of the stem cell marker SOX2 and modulates epithelial-mesenchymal transition through interactions with Notch1 and β-catenin (Nie et al., 2021).